7-(1-acryloyl-4-piperidinyl)-2-(4-phenoxyphenyl)-4,5,6,7-tetrahydropyrazolo(1,5-a)pyrimidine-3-carboxamide,
BGB-3111,
zanubrutinib,
BGB-3111,
1633350-06-7,
( inverted exclamation markA)-Zanubrutinib,
1691249-45-2,
CHEMBL3973435,
SCHEMBL16208602,
SCHEMBL19742851,
BGB3111,
BDBM249900,
BCP25045,
BCP25838,
BCP29110,
AKOS032946689,
CS-6366,
SB18877,
( inverted exclamation markA)-BGB-3111,
HY-101474,
US9447106, 27,
Pyrazolo[1,5-a]pyrimidine-3-carboxamide, 4,5,6,7-tetrahydro-7-[1-(1-oxo-2-propen-1-yl)-4-piperidinyl]-2-(4-phenoxyphenyl)-,
Zanubrutinib,
(R)-Zanubrutinib,
((plusmn))-Zanubrutinib,
1691249-44-1,